Johannes Kast Selected Research

Neoplasms (Cancer)

1/2023	Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma.
1/2022	Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T-cellular therapy development.
1/2021	Panitumumab: A Review of Clinical Pharmacokinetic and Pharmacology Properties After Over a Decade of Experience in Patients with Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes Kast Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2021
1	Melanoma (Melanoma, Malignant) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Body Weight (Weight, Body) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Sleepiness 11/2018
1	Pneumoperitoneum 10/2018

Drug/Important Bio-Agent (IBA)

1	talimogene laherparepvecIBA 01/2023
1	AN 12IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Modafinil (Provigil)FDA Link 11/2018

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
1	Oncolytic Virotherapy 01/2023
1	Esophagectomy 10/2018